White House spokesman Josh Earnest says pharmaceutical firms risk damaging their reputations "by being greedy and jacking up prices" amid criticism over Mylan NV's sharp cost hike of its allergy drug EpiPen. Rough Cut (no reporter narration).
Read more
No comments:
Post a Comment